Skip to main content
. 2018 Jan 16;6(1):1–5. doi: 10.12998/wjcc.v6.i1.1

Table 1.

CDH1 related cancer risks and International Gastric Cancer Linkage Consortium 8th workshop management recommendations

Gastric cancer Lobular breast cancer Colon cancer
Lifetime cancer risk 80% 60% Unknown
Surveillance EGD surveillance in persons not willing to undergo prophylactic gastrectomy Annual clinical breast exams Colon cancer screening in HDGC families with colon cancer from age 40 or 10 yr younger than the youngest diagnosis of colon cancer
If CDH1 + with no evidence of cancer, EGD surveillance, usually starting at age 16 until time of prophylactic gastrectomy per IGCLC 7 guideline[11] Bilateral breast MRI starting at age 30 Repeat colonoscopy at 3-5 yr intervals per IGCLC 7 guidelines[11]
Therapy Suggest prophylactic gastrectomy between age 20-30 if CDH1 + without evidence of cancer Suggests gastrectomy if evidence of cancer regardless of age Prophylactic mastectomy not recommended, but may be considered on case by case basis Not available

EGD: Esophagogastroduodenoscopies; HDGC: Hereditary diffuse gastric cancer; IGCLC: International Gastric Cancer Linkage Consortium.